Pierre NAHON

Professor of Hepatology, APHP, Bobigny, France

Professor of Hepatology, Avicenne Hospital in Bondy, APHP, France
Professor NAHON gained his medical degree from the University of Paris 13, before undertaking a PhD in biology.

Professor NAHON’s research interests focus on the complications of cirrhosis, in particular hepatocellular carcinoma. He is the Scientific Coordinator of the French National Agency for Research on AIDS and Viral Hepatitis CO12 CirVir cohort, which is a prospective follow-up of nearly 1800 patients with compensated viral cirrhosis and sequential biobanks in 35 centres across France currently under exploration for multiple biomarker studies (RHU DELIVER). He also coordinates a WP dedicated to AI, biomarkers and HCC surveillance in the setting of the GENIAL H2020 European project.

Professor NAHON is also the co-Coordinator of a GWAs within the Genetic work package of the French Hepatocellular Carcinoma Multi-technological Project (HECAM) published in the Lancet Oncology. He also obtained funding for the implementation of multicentric Phase 2 trials testing the efficacy of combining percutaneous ablation with neo- and adjuvant immunotherapy or TKI for the treatment of hepatocellular carcinoma (NCT03630640 NIVOLEP, NCT05113186 LENVABLA and NCT06045975 DUMELEP trials).
More recently, he coordinates an academic randomized trial testing abbreviated MRI for the early detection of HCC in high-risk patients with cirrhosis (NCT05095714 FASTRAK trial).